Eli Lilly to launch up to four new weight‑loss drugs in next four years
Based on · First reported
Sources
- Eli Lilly's chairman and CEO David A. Ricks announced the company will introduce up to four new products in the weight‑loss category over the next four years, building on the $36 billion sales generated last year by Mounjaro and Zepbound. The firm, valued at $1.05 trillion, aims to maintain its lead in the market.
- Ricks highlighted India's strong scientific talent and manufacturing capabilities, stating that Lilly is open to discussions with Indian biotechnology companies for potential partnerships.
How we use AI · Report an error
Related stories
- U.S. Coast Guard searches for missing Gulfstream G100 off Nantucket
- Vilnius Airport shut after suspected Belarusian drone sighting
- Tigray Peace Forces claim full control of Mekelle Alula Aba Nega Airport
- FlyDubai Flight 1073 diverted to Saudi Arabia after cockpit stabbing
- Gulfstream G100 private jet disappears after departing Bermuda for Boston